Janus kinase inhibitors in systemic lupus erythematosus: implications for tyrosine kinase 2 inhibition

Aberrant activation of the Janus kinase (JAK) and signal transducer and activator of transcription (STAT) pathway is common in systemic lupus erythematosus (SLE), conferring immune-mediated properties in target tissues. Multiple cytokines activate different combinations of JAKs and STATs to alter th...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikolopoulos, Dionysis, Parodis, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344364/
https://www.ncbi.nlm.nih.gov/pubmed/37457579
http://dx.doi.org/10.3389/fmed.2023.1217147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344364/
https://www.ncbi.nlm.nih.gov/pubmed/37457579
http://dx.doi.org/10.3389/fmed.2023.1217147

Ejemplares similares